ID: ALA5181861

Max Phase: Preclinical

Molecular Formula: C28H27N5O2

Molecular Weight: 465.56

Representations

Canonical SMILES:  COc1ccc(Nc2cc3nc4ccccc4n(-c4ccc(OC)nc4)c-3c/c2=N\C(C)C)cc1

Standard InChI:  InChI=1S/C28H27N5O2/c1-18(2)30-24-16-27-25(15-23(24)31-19-9-12-21(34-3)13-10-19)32-22-7-5-6-8-26(22)33(27)20-11-14-28(35-4)29-17-20/h5-18,31H,1-4H3/b30-24+

Standard InChI Key:  DAOGHIAHFATGIG-BGABXYSRSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 465.56

Molecular Weight (Monoisotopic): 465.2165

AlogP: 5.60

#Rotatable Bonds: 6

Polar Surface Area: 73.56

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa: 6.83

CX LogP: 5.16

CX LogD: 5.05

Aromatic Rings: 3

Heavy Atoms: 35

QED Weighted: 0.33

Np Likeness Score: -1.02

References

1. Zhang X, Shi Y, Guo Z, Zhao X, Wu J, Cao S, Liu Y, Li Y, Huang W, Wang Y, Liu Q, Li Y, Song D..  (2022)  Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism.,  234  [PMID:35279610] [10.1016/j.ejmech.2022.114209]

Source

Source(1):

• Scientific Literature